The advent of medical technology, combined with aging populations, results in healthcare costs representing an ever increasing proportion of GDP and government spending in most developed countries. Optimization of healthcare resources has therefore become a crucial and urgent challenge. In this context, the tools and methodologies provided by the disciplines of health economics / HTA are increasingly indispensable to the pharmaceutical/medical technology industries, as well as to governments and health insurance organizations. MYO covers all aspects of health economics/HTA, including:

Systematic Literature Review (SLR)

Cost-effectiveness models (original and/or country adaptation)

Budget Impact models (original and/or country adaptation)

Complete Value Dossers in support of reimbursement and Market Access

Authoring of ISPOR posters

Presentation of ISPOR posters

Authoring of full manuscripts

Publication of manuscripts in peer reviewed medical journals

Health Economics Project Map

world-map

Case Study 1

As subcontractors to a California-based consulting group and on behalf of an insulin pump manufacturer, MYO conducted a systematic literature search on diabetes, including disease incidence and demographics, as well as treatments, their complications and associated costs and use of resources.

We used this input to populate a comprehensive database, which enabled US diabetes physicians, as well as the client's own Marketing, Sales and R&D staff to have a global overview of literature findings in a tiny fraction of the time it would normally take.

One of the most useful features of this database was the inclusion of standardized 1-page summaries for all clinical studies involving the client's technology.


Case Study 2

A US-based medical device manufacturer was interested to assess the potential for its body-cooling technology to improve clinical and economic outcomes in patients with neurogenic fever due to stroke or traumatic brain injury.

MYO conducted a systematic search of the clinical and health economics literature for documentation of the impact of thermoregulation in treating patients with neurogenic fever. Findings were subsequently used to conduct a statistical meta-analysis of the acceptable literature.

At the client’s request, MYO consultants co-authored a clinical article presenting relevant findings (D Greer, S Funk, N Reaven, M Ouzounelli, G Uman. Impact of fever on outcome in patients with stroke and neurologic injury. Stroke 2008;39(11):3029-35).